Table 1.

Changes in HBV viral load and ALT before, during, and after chemotherapy in 5 individuals with evidence of reactivation

Before chemotherapy
Maximum during chemotherapy
After chemotherapy
HBV viral load (age, y)    
   Patient no. 1 (41)   0   2.3 × 109  1.4 × 109 
   Patient no. 2 (36)   0   2500   0  
   Patient no. 3 (38)   0   7500   0  
   Patient no. 4 (41)   0   1150   45 350  
   Patient no. 5 (56)   0   2500   0  
   Median HBV viral load*  0   2500 ± 108  0 ± 6 × 108 
Alanine aminotransferase    
   Median ALT in patient nos. 1 to 5*  19 ± 14 × 103  95 ± 78 × 103  24 ± 12 × 103 
   Median ALT in 56 individuals without reactivation*
 		 29 ± 41 × 103
 		 101 ± 136 × 103
 		 33 ± 75 × 103
 
Before chemotherapy
Maximum during chemotherapy
After chemotherapy
HBV viral load (age, y)    
   Patient no. 1 (41)   0   2.3 × 109  1.4 × 109 
   Patient no. 2 (36)   0   2500   0  
   Patient no. 3 (38)   0   7500   0  
   Patient no. 4 (41)   0   1150   45 350  
   Patient no. 5 (56)   0   2500   0  
   Median HBV viral load*  0   2500 ± 108  0 ± 6 × 108 
Alanine aminotransferase    
   Median ALT in patient nos. 1 to 5*  19 ± 14 × 103  95 ± 78 × 103  24 ± 12 × 103 
   Median ALT in 56 individuals without reactivation*
 		 29 ± 41 × 103
 		 101 ± 136 × 103
 		 33 ± 75 × 103
 

HBV viral load is measured in copies/mL, and ALT in U/L.

*

Medians ± standard deviations are shown

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal